Original-Research: MAX Automation SE (von NuWays AG)

Original-Research: MAX Automation SE - from NuWays AG

Classification of NuWays AG to MAX Automation SE

Company Name: MAX Automation SE
ISIN: DE000A2DA588

Reason for the research: Update
Recommendation: Kaufen
from: 15.05.2024
Target price: EUR 8.20
Target price on sight of: 12 Monaten
Last rating change: 
Analyst: Konstantin Völk

Muted start into the year but solid order intake; chg. est.
 
Topic: MAX released mixed Q1 results with muted sales and slight pressure
on margins in line with expectations. However, order intake moderately
improved qoq from a low level in the last three quarters
supported by continuous follow-up orders from ELWEMA.
 
Q1 group sales declined slightly by 6.1% yoy to € 91m (eNuW: € 92m)
reflecting the low order backlog compared to last year. Q1 EBITDA fell by
18% yoy to € 7.9m (eNuW: € 7.6m) due to the lower top-line, wage inflation
and a product mix shift within bdtronic. Hence, the margin declined by
1.2pp yoy to 8.8%.
 
After three weaker quarters, order intake in Q1 showed first signs of a
recovery. Q1 group order intake increased 26% qoq to € 90m but decreased
21% yoy compared to the exceptionally strong Q1 FY23. Order intake in the
second half of FY23 suffered from investment restraints reflecting a
challenging macroeconomic environment, restrictive financing conditions and
persistently high price levels. The ongoing weakness of the global economy
was in particular delt in the German mechanical and plant engineering
sector. We expect the situation to improve modestly in the second half of
FY24e, which should translate to increasing revenue in FY25e.
 
bdtronic continued its growth story and increased sales by 50% yoy to €
29.6m supported by a high order backlog and strong service business.
However, EBITDA stayed unchanged yoy at € 3.3m along with a margin decrease
of 5.6pp to 11.1%. This was largely influenced by a product mix shift to
the lower margin impregnation business as well as wage inflation and an
increase in personnel.
 
Vecoplan’s revenues came in at € 38.7m, a 16.2% decrease yoy. EBITDA fell
by 27% to € 4.1m with a slight margin reduction of 1.6pp to 10.5% due to
investment reluctance in the recycling/waste division and positive one-offs
from the reversal of provisions in the previous year. We expect Vecoplan to
stabilize on a plateau this year with a flat development in sales and a
slight decrease in EBITDA.
 
MAX confirmed its FY24e guidance of € 390-450m sales (eNuW: € 411m) and €
31-38m EBITDA (eNuW: € 33m). This appears sensible in our view as it
implies a 5.7% top-line increase and a flat development in EBITDA at
midpoint.
 
We reiterate BUY with an unchanged PT of € 8.20, based on DCF.

You can download the research here:
http://www.more-ir.de/d/29745.pdf
For additional information visit our website
www.nuways-ag.com/research.

Contact for questions
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++

-------------------transmitted by EQS Group AG.-------------------


The issuer is solely responsible for the content of this research.
The result of this research does not constitute investment advice
or an invitation to conclude certain stock exchange transactions.
This website uses cookies. Please see our privacy guidelines for further details.